Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Share News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
64.00    0.30 (0.47%)
Bid:
63.60
Ask:
64.30
Spread: 0.70 (1.101%)
Market Cap: £565.39m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Ip Group News

TOP NEWS: Hambro Perks will not merge with IP Group drug firm Istesso
30 Jan 2023

TOP NEWS: Hambro Perks will not merge with IP Group drug firm Istesso

(Alliance News) - Hambro Perks Acquisition Co Ltd on Monday responded to press speculation, saying it will not merge with Istesso Ltd, a London-based ...

IP Group dashes speculation of a possible business combination involving Istesso
30 Jan 2023

IP Group dashes speculation of a possible business combination involving Istesso

(Sharecast News) - IP Group said talks regarding a possible business combination involving its Istesso, one of its portfolio companies, had been termi...

IN BRIEF: IP Group appoints GSK's Anita Kidgell as non-executive
18 Jan 2023

IN BRIEF: IP Group appoints GSK's Anita Kidgell as non-executive

IP Group PLC - Oxford, England-based intellectual property commercialisation company - Appoints Anita Kidgell as an independent non-executive director...

IP Group portfolio company Oxbotica raises GBP115 million
11 Jan 2023

IP Group portfolio company Oxbotica raises GBP115 million

(Alliance News) - IP Group PLC on Wednesday said its portfolio company Oxbotica Ltd has raised GBP115 million in a series C investment round.

CORRECTED (OFFICIAL)-Oxbotica raises $140 mln to deploy self-driving commercial vehicles
11 Jan 2023

CORRECTED (OFFICIAL)-Oxbotica raises $140 mln to deploy self-driving commercial vehicles

LONDON, Jan 11 (Reuters) - Self-driving software startup Oxbotica has raised $140 million from investors to speed deployment of autonomous vehicles ...

IP Group portfolio company gains FDA fast track status for lead drug
5 Dec 2022

IP Group portfolio company gains FDA fast track status for lead drug

(Alliance News) - IP Group PLC on Monday announced that its majority-owned portfolio company, Istesso Ltd, has been granted fast track designation for...

IP Group portfolio company begins phase two trial of arthritis drug
31 Aug 2022

IP Group portfolio company begins phase two trial of arthritis drug

(Alliance News) - IP Group PLC on Wednesday reported that its majority-owned portfolio company, Istesso Ltd, has begun a phase 2b trial of its lead dr...